Radleys Announces Agreement With Syrris to Focus on US Process Development Markets
News Oct 17, 2005
Radleys has announced an exclusive distribution agreement with Syrris Inc. to spearhead its North American sales and technical support.
The agreement covers sales and support of the Lara Controlled Laboratory Reactor (CLR) system and Coflux Calorimetry module in North America.
Asked about the arrangement Mark Radley, Managing Director of Radleys said, “With the demand for Lara in North America accelerating we are pleased to announce the new arrangement with Syrris Inc. to provide an enhanced level of local support to customers.”
“Having a strong background in microreactor technology and flow chemistry - Syrris already are talking to many of the development and discovery chemists who might gain from the many benefits offered by the Lara CLR range.”
Richard Gray, Commercial Director of Syrris Inc. added, “the addition of the Lara CLR range perfectly fits our target market focus and knowledge base.”
“This new appointment by Radleys ensures that customers in North America will receive the very best sales and technical support.”
The Lara CLR is a flexible and modular chemical reactor that is both affordable and highly automated.
Offering a choice of hardware and software components designed to provide comprehensive data logging and reliability the Lara CLR has been adopted as a process automation tool of choice by a rapidly growing number of pharmaceutical and chemical companies worldwide.
The Coflux reaction monitoring module extends the capabilities of the Lara CLR system to provide realtime calorimetry information on power and enthalpy readings without relying on any time-consuming baseline calibrations.
Radleys claims that, the system not only accurately produces heat of reaction and maximum heat flow data needed for hazard assessment to scale-up a process to pilot plants or production units but also generates the information for process monitoring, analysis and optimisation.
18th International Conference on Pharmaceutics & Novel Drug Delivery Systems
May 27 - May 28, 2019
Global Experts Meeting on Frontiers in Biosimilars and Biologics Congress
Oct 24 - Oct 26, 2019